White label ELPA - ClinicalTrials.eu

A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

Recruiting

3 1 1
Investigated drugs:
- Depemokimab
- Salbutamol Sulfate
+6
Study on the Use of [18F]PSMA-1007 PET/CT Imaging for Detecting Prostate Cancer in Patients with Newly Diagnosed High-Risk or Very-High-Risk Conditions

Recruiting

3 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- (2S)-2-[[(1S)-1-Carboxy-5-[[(2S)-2-[[4-[[[(2S)-4-Carboxy-2-[[(2S)-4-Carboxy-2-[(6-(18F)Fluoranylpyridine-3-Carbonyl)Amino]Butanoyl]Amino]Butanoyl]Amino]Methyl]Benzoyl]Amino]-3-Naphthalen-2-Ylpropanoyl]Amino]Pentyl]Carbamoylamino]Pentanedioic Acid
Study on the Safety and Effectiveness of C1 Esterase Inhibitor and Sodium Chloride for Patients with Aneurysmal Subarachnoid Hemorrhage

Recruiting

2 1 1
Investigated diseases:
- Subarachnoid haemorrhage
Investigated drugs:
- C1 Esterase Inhibitor (Human)
- Sodium Chloride
Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

Recruiting

2 1 1
Investigated diseases:
- Neoplasm
- Non-small cell lung cancer metastatic
Investigated drugs:
- VERT-002
A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Recruiting

4 1 1 1
Investigated diseases:
- Age-related macular degeneration
Investigated drugs:
- Fluorescein Sodium
- Aflibercept
+4
Evaluation of mRNA-4359 Monotherapy and Combined Pembrolizumab Therapy in Advanced Solid Tumors: A Phase 1/2 Clinical Trial

Recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer metastatic
Investigated drugs:
Phase 1/2 Evaluation of Zilovertamab Vedotin in PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma

Recruiting

2 1 1 1
Investigated diseases:
- Transitional cell carcinoma metastatic
Investigated drugs:
Study on Metformin and Colchicine for Patients with Long COVID Symptoms

Recruiting

3 1 1
Investigated diseases:
- Post-acute COVID-19 syndrome
Investigated drugs:
Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Recruiting

3 1 1 1
Investigated drugs:
+4
Study on Early Detection of Triple-Negative Breast Cancer Relapse Using 68Ga-FAPI-46 for Patients at High Risk

Recruiting

2 1 1
Investigated diseases:
- Triple negative breast cancer
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies